[Osteopetrosis in mice caused by ectomesenchymal lesions]

Area of Science:

• Developmental biology
• Genetics
• Hematology

Context:

• Osteopetrosis is a rare genetic disorder characterized by impaired osteoclast function, leading to bone sclerosis.
• The microphthalmia (mi) mouse model exhibits osteopetrosis due to a mutation affecting neural crest development.
• Heparin, a glycosaminoglycan, plays roles in various biological processes, including bone metabolism and cell differentiation.

Purpose:

• To investigate the pathogenesis of osteopetrosis in microphthalmia (mi/mi) mutant mice.
• To determine the role of heparin and mast cells in the skeletal abnormalities observed in mi/mi mice.
• To evaluate the therapeutic potential of heparin administration in ameliorating osteopetrosis in this model.

Summary:

• Mice homozygous for the microphthalmia (mi) mutation display significantly reduced blood heparin concentrations (10-fold lower than normal).
• Administration of exogenous heparin (1, 5, or 10 per g body weight) during specific postnatal periods (days 2-25) partially or completely normalized the diaphyseal structure of long bones.
• A reduced number of heparin-secreting mast cells, originating from neural crest cells, was observed in mi/mi mice, suggesting a link between neural crest defects, mast cell deficiency, and osteopetrosis.

Impact:

• These findings highlight the critical role of heparin and neural crest-derived mast cells in bone development and osteoclast function.
• The study suggests that osteopetrosis in mi/mi mice is part of a complex syndrome resulting from neural crest cell damage.
• Heparin administration presents a potential therapeutic strategy for managing bone abnormalities in osteopetrosis models.